How long do you need to take weight loss injections?

Why is there no set finishing line with these medicines?

Unlike a course of antibiotics, weight loss injections don't have a built-in stop date. Medicines like tirzepatide (Mounjaro) and semaglutide (Wegovy) work by influencing the hormonal signals that regulate appetite and how your body uses energy. Those signals don't permanently reset while you're on treatment, they calm down. When treatment stops, they tend to reassert themselves, which is why weight regain after stopping is a documented pattern rather than a personal failure.

The clinical trials that established these medicines (including the 72-week SURMOUNT-1 trial of tirzepatide and the 68-week STEP 1 trial of semaglutide, both published in the New England Journal of Medicine) studied participants over roughly 16–18 months. They showed that weight loss continued to accumulate across that period, rather than peaking early and plateauing. That shape matters: stopping at month six means stopping before most of the benefit has been reached.

There is also the question of individual variation. Some people respond strongly at lower doses; others need longer to reach their maintenance dose. A prescriber reviewing your progress month by month is much better placed than any guideline to say when continuing makes sense and when it might not.

Does guidance give any indication of typical duration?

For NHS use of semaglutide (Wegovy), NICE set a maximum of two years within a specialist weight management service, this applies specifically to the NHS pathway and reflects the scope of the appraisal, not a biological ceiling on how long the medicine can safely work. Tirzepatide's NICE appraisal (TA1026) does not set the same two-year cap; it does say that if less than five per cent of body weight has been lost after six months at the highest tolerated dose, continuing should be reconsidered.

Private treatment operates under the same clinical principles but is not bound by the same commissioning rules. Your prescriber reviews suitability before each repeat order, at nume there are no auto-renewals, and every new supply requires that clinical re-check. That structure exists precisely so that duration is decided on your health, not on a subscription timer. If you're weighing up how long you can take weight loss injections as a practical question, the short version is: as long as clinical review supports it.

For a sense of how the cost of ongoing treatment fits into the picture, our guide to what weight loss injections cost lays out what a private prescription typically includes.

What happens if you stop, and can you restart?

This is the part that catches people off guard. Studies following participants after they stopped GLP-1 medicines found that a significant proportion of the weight lost was regained within a year of stopping, even among those who maintained lifestyle changes. The mechanism is the same as why the medicines work: once the appetite-regulating effect is withdrawn, hunger signals tend to return toward baseline.

That doesn't mean stopping is always wrong. Some people reach a stable weight, embed lasting habits, and make an informed decision with their prescriber to step down. Others pause treatment for medical reasons (surgery, pregnancy planning, or a period of illness) and restart later. Restarting is clinically possible and is treated as a new assessment; the prescriber considers your current health, any changes since you last took the medicine, and the appropriate starting dose.

The NHS patient information on tirzepatide and the equivalent page for semaglutide both advise not stopping or adjusting your dose without speaking to your prescriber first. That's the right instinct: a conversation beats a unilateral decision either way. You can also read about how often these injections are taken and how long they typically take to show results if you're still building a picture of what treatment looks like day to day.

How does a prescriber decide when to continue or stop?

At each clinical review, a prescriber is looking at several things at once: how much weight has been lost and over what period, whether you're tolerating the current dose well, any changes to your health or medicines, and whether the benefit still outweighs any risks for you personally. It's an active, ongoing clinical judgement, not a passive tick-box.

The five per cent rule from NICE is a useful prompt: if someone has been at the highest dose they can tolerate for six months and the scale hasn't moved meaningfully, that's the moment to reassess whether continuing is the right call. But for people who are responding well and tolerating treatment, continuation is generally supported by the evidence. The goal isn't a number on the scale; it's sustained health improvement, and how long that takes varies widely.

If you'd like a clearer sense of what a longer-term treatment journey looks like, our page on weight loss injections covers both medicines in more detail. And if you have questions specific to your situation, our FAQs cover many of the most common ones.